Dear Editor,
I would like to give my response to Mungmunpuntipantip and Wiwanitkit’s Letter to the Editor, “Late diagnosis of COVID-19 and hypercoagulable state” [1], which cited my paper “Late diagnosis of COVID-19 in a 34-year-old man in a hypercoagulable state: A case report” [2].
Based on the case, this patient was initially treated by an internist in a small hospital and was diagnosed and treated as Dengue Hemorrhagic Fever patient; however, there was no improvement and the condition even worsened, oxygen saturation decreased, then the patient was referred to a larger hospital. After a Polymerase Chain Reaction (PCR) examination, the results were positive, and then the patient was diagnosed and treated as COVID-19 patient, but because the patient already had a severe hypercoagulable condition, the patient could not be helped [3–5].
REFERENCES
- 1.Mungmunpuntipantip R, Wiwanitkit V. Re: Late diagnosis of COVID-19 and hypercoagulable state. Can J Respir Ther 2022;58:84. doi: 10.29390/cjrt-2022-026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Desdiani D. Late diagnosis of COVID-19 in a 34-year-old man in a hypercoagulable state: a case report. Can J Respir Ther 2022. Apr 20;58:49–52. doi: 10.29390/cjrt-2021-028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Klok FA, Kruip MJHA, Van der Meer NJM, et al. Incidence of thrombotic complication in critically ill ICU patient with COVID-19. Thromb Res 2020;191:145–7. doi: 10.1016/j.thromres.2020.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020;7(6):e438–40. doi: 10.1016/S2352-3026(20)30145-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2020;2(7):e437–45. doi: 10.1016/S2665-9913(20)30121-1. [DOI] [PMC free article] [PubMed] [Google Scholar]